To direct the Secretary of Veterans Affairs to conduct a pilot program on the provision of naloxone to veterans and their caregivers, and for other purposes.
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™This bill directs the Secretary of Veterans Affairs to conduct a pilot program to provide naloxone, a medication used to reverse opioid overdoses, to veterans and their caregivers. The program aims to address opioid overdose risks among veterans by increasing access to this life-saving drug. The bill was introduced in the House during the 118th Congress but did not advance beyond referral to the Subcommittee on Health and ultimately failed or expired.
The bill sought to implement a pilot program for naloxone distribution to veterans and caregivers through the Department of Veterans Affairs but did not progress in Congress and is no longer active.
- The bill mandates a pilot program specifically focused on providing naloxone to veterans and their caregivers.
- It assigns responsibility to the Secretary of Veterans Affairs for program implementation.
- The bill was referred to the House Subcommittee on Health but did not advance further and expired.
['Veterans at risk of opioid overdose', 'Caregivers of veterans', 'Department of Veterans Affairs as the implementing agency']
['The bill text and summary do not specify funding sources or program duration, which could affect implementation feasibility.', 'Oversight and evaluation mechanisms for the pilot program are not detailed, potentially limiting accountability.', 'The absence of full bill text limits understanding of specific eligibility criteria or program scope.']
The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health. It falls within the policy area of Armed Forces and National Security, reflecting ongoing legislative interest in addressing opioid-related health risks among veterans. However, the bill did not advance and expired, indicating limited legislative momentum or prioritization.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Increased access to naloxone among veterans and caregivers could reduce opioid overdose fatalities in this population.', 'The pilot program may inform future broader policies on opioid overdose prevention within the Veterans Affairs healthcare system.', 'Successful implementation could lead to expanded naloxone distribution programs for other at-risk groups served by the VA.']
The absence of full bill text and official summary limits comprehensive analysis. Key transparency considerations include the need for clear funding sources, defined program parameters, and oversight mechanisms to ensure effective implementation and accountability. Monitoring legislative progress and any subsequent related proposals is recommended to track policy developments in veteran opioid overdose prevention.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.